They called themselves the Collaborative Pain Research Unit, and their biomarker "breakthrough" was big news at the time. Newspapers around the world ran the story.
They claimed to have a pair of diagnostic biomarkers, CFSUM1 and CFSUM2. These were urine tests.
They used to carry out a range of additional blood, urine and stool tests. From this they thought they could subtype CFS patients. In addition, they profiled patients individually, with a view to being able to design individual treatment programs.
Aside from their own lab tests, they arranged the following tests:
Mycoplasma DNA via PCR
Rickettsia DNA via PCR
RNase L
Interleukin 2
A quick update on the Newcastle team:
- Hugh Dunstan is still a professor in Newcastle.
- Tim Roberts retired from Newcastle in 2008, and is now a professor in Singapore. He also flogs "Fatigue reviva", an amino-acid miracle (?) potion
- Neil McGregor remains a practicing dentist (periodontist). He's now in Melbourne. He got into CFS via an interest in chronic pain, which was the subject of his dental PhD, I think.
-Henry Butt was covered in earlier posts.